Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

2030 ARTíCULOS , VIENDO DEL 61 AL 75

PUBMED

Quetiapine in the treatment of psychosis in Parkinson's disease.

Shotbolt P, Samuel M, David A.

Ther Adv Neurol Disord. 2010 Nov;3(6):339-50. doi: 10.1177/1756285610389656.

0

0

0

PUBMED

The role of pramipexole in a severe Parkinson's disease model in mice.

Elhak SG, Ghanem AA, Abdelghaffar H, Eldakroury S, Eltantawy D, Eldosouky S, Salama M.

Ther Adv Neurol Disord. 2010 Nov;3(6):333-7. doi: 10.1177/1756285610389655.

0

0

0

PUBMED

Striatal spine plasticity in Parkinson's disease.

Villalba RM, Smith Y.

Front Neuroanat. 2010 Dec 10;4:133. doi: 10.3389/fnana.2010.00133.

0

0

0

PUBMED

The neurotoxicity of DOPAL: behavioral and stereological evidence for its role in Parkinson disease pathogenesis.

Panneton WM, Kumar VB, Gan Q, Burke WJ, Galvin JE.

PLoS One. 2010 Dec 13;5(12):e15251. doi: 10.1371/journal.pone.0015251. Erratum in: PLoS One. 2011;6(2). doi: 10.1371/annotation/819cbf4a-7e3e-4e4e-a449-b667bc6e8957.

0

0

0

PUBMED

Attention modulation regulates both motor and non-motor performance: a high-density EEG study in Parkinson's disease.

Perfetti B, Moisello C, Lanzafame S, Varanese S, Landsness EC, Onofrj M, Di Rocco A, Tononi G, Ghilardi MF.

Arch Ital Biol. 2010 Sep;148(3):279-88.

0

0

0

PUBMED

Recent advances in the assessment and treatment of falls in Parkinson's disease.

Snijders AH, Nonnekes J, Bloem BR.

F1000 Med Rep. 2010 Oct 21;2:76. doi: 10.3410/M2-76.

0

0

0

PUBMED

Contributions of the Instituto Nacional de Cardiología in the diagnosis and treatment of the Wolff-Parkinson - White syndrome.

Iturralde-Torres P, Márquez MF.

Arch Cardiol Mex. 2010 Oct-Dec;80(4):329-37. Review.

0

0

0

PUBMED

Therapeutic efficacy of the neuroprotective plant adaptogen in neurodegenerative disease (Parkinson's disease as an example).

Bocharov EV, Ivanova-Smolenskaya IA, Poleshchuk VV, Kucheryanu VG, Il'enko VA, Bocharova OA.

Bull Exp Biol Med. 2010 Nov;149(6):682-4.

0

0

0

PUBMED

[Health-related quality of life in Parkinson's disease].

Cano-de la Cuerda R, Vela-Desojo L, Miangolarra-Page JC, Macías-Macías Y, Muñoz-Hellin E.

Medicina (B Aires). 2010;70(6):503-7. Spanish.

0

0

0

PUBMED

[Burden and related factors among care-takers of patients with Parkinson's disease].

He HY, Zhou MZ, Lu LX, Wu JY, Gan J, Chen W, Liu ZG.

Zhonghua Liu Xing Bing Xue Za Zhi. 2010 Jun;31(6):692-5. Chinese.

0

0

0

PUBMED

Care of patients with Parkinson's disease in the operating department.

Holland J.

J Perioper Pract. 2010 Nov;20(11):406-10.

0

0

0

PUBMED

Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study.

Weintraub D, Sohr M, Potenza MN, Siderowf AD, Stacy M, Voon V, Whetteckey J, Wunderlich GR, Lang AE.

Ann Neurol. 2010 Dec;68(6):963-8. doi: 10.1002/ana.22164.

0

0

0

PUBMED

Homonymic puns and Parkinson's disease.

Robinson JD.

Health Commun. 2010 Dec;25(8):770-1. doi: 10.1080/10410236.2010.521924. No abstract available.

0

0

0

PUBMED

The yin and yang of VEGF and PEDF: multifaceted neurotrophic factors and their potential in the treatment of Parkinson's Disease.

Falk T, Gonzalez RT, Sherman SJ.

Int J Mol Sci. 2010 Aug 5;11(8):2875-900. doi: 10.3390/ijms11082875. Review.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy